Description: Medibio Limited, a medical health technology company, engages in the development of diagnostic systems for mental health illnesses in Australia and the United States. It is involved in the research, development, and commercialization of mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions. The company was formerly known as BioProspect Limited and changed its name to Medibio Limited in November 2014. Medibio Limited was founded in 1998 and is based in South Melbourne, Australia.
Home Page: medibio.com.au
100 Albert Road
Melbourne,
VIC
3205
Australia
Phone:
61 3 9692 7222
Officers
| Name | Title |
|---|---|
| Dr. Thomas R. Young M.D. | Chief Exec. Officer |
| Ms. Renee Stanton-Horne | Operations & Account Mang. |
| Ms. Stephanie Ottens | Investor Relations Director |
| Mr. Josh Purdy | PR Director |
| Dr. Michael Player | Head of Research |
| Dr. Matthew Flax | Head of Algorithm Devel. Team |
| Mr. Archie Defillo M.D. | Chief Medical Officer |
| Ms. Jennifer Solitario | Sr. VP of Corp. Health |
| Mr. Massimiliano Grassi | Head of Artificial Intelligence |
| Mr. Mathew Watkins C.A. | Company Sec. |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.7586 |
| Price-to-Sales TTM: | 3.6329 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |